конгресс 2018
icglaucoma.org
santen
ВК
facebook
www.worldglaucoma.org
askin_heid
Основные мероприятия ассоциации офтальмологов
Флаги
glaucoma_net_ru
Конгресс
icgs2018
Шахматы
Первая пятница декабря
medlab
АйНьюс.РФ
Beaver
Торика
YouTube
bannerparasol
varthamana2
oftalmolog_club
nidek
eye5
Ассоциации
Конгресс 2014
профессор
appstore
Mobile
camopht
Главная / Новости

Новости


1 2 3 4 5 6 7 8 9 10


01 февраля 2018 - Готовь плавки зимой) 13th EGS Congress, Florence 2018 (май)
Приглашение Президента на Конгресс! Будет хорошо!

30 января 2018 - Лидеры всемирной глаукомной ассоциации поменялись... Leadership changes
Кто говорит, что ротация это плохо? 2018 starts with welcoming a new WGA President: Keith Martin, Professor and Head of Ophthalmology, University of Cambridge, UK. The new President Elect is Fabian Lerner, Professor of Ophthalmology, University Favaloro School of Medical Sciences in Buenos Aires, Argentina. At the Executive Office we welcome Shan Lin, Professor of Clinical Ophthalmology at the University of California, San Francisco, US as Executive Vice President and Kaweh Mansouri, Consultant at the Glaucoma Center, Montchoisi Clinic, Lausanne, Switzerland as Associate Executive Vice President. New members of the WGA Board of Governors per 2018 are Arthur Sit (Rochester, Minnesota United States), Ingeborg Stalmans (Leuven, Belgium), Fotis Topouzis (Thessaloniki, Greece) and Lingam Vijaya (Chennai, India).

29 января 2018 - Patients’ Treatment Preferences For most patients, starting an eye drop is the simplest first step. By Atalie C. Thompson, MD, MPH, and Kelly W. Muir, MD, MHS
When patients receive a new diagnosis of glaucoma, they suddenly face the numerous, complex trade-offs in risks and benefits posed by the three main options for therapy—medications, laser surgery, and incisional surgery. For a majority of patients, starting a topical glaucoma medication is the most intuitive first step of treatment. The practice of instilling eye drops may be familiar if they wear contact lenses or have administered topical ophthalmic solutions for dry eye disease or allergic conjunctivitis. Moreover, for many of them, daily medication use is already a part of their routine.

28 января 2018 - Uniting Over 500 Leaders in the Development of Ground-Breaking Ophthalmic Technologies
Апрель, похоже, будет насыщенным!

26 января 2018 - Successful Outcomes With the Xen Gel Stent
Clinical Minute distills a peer-reviewed study into what is relevant for practicing clinicians/surgeons in approximately one minute. In the debut episode of this series, Neda Shamie, MD, outlines a recent paper by Iqbal Ike K. Ahmed, MD, FRCSC, on the Xen implant (Allergan). The paper offers surgical pearls and patient management protocols to ensure successful outcomes with this microinvasive glaucoma surgical device.

25 января 2018 - Pharmacogenomics and Personalized Medicine. "Персональная" медицина
What is the advantage to you of publishing in Pharmacogenomics and Personalized Medicine? It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website. Although Pharmacogenomics and Personalized Medicine receives many papers, unlike most traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish. The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Pharmacogenomics and Personalized Medicine has a quicker turnaround time than this. Generally peer review is complete within 4-7 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 9 weeks for a final decision. Many authors have found that our peer reviewer’s comments substantially add to their final papers.

23 января 2018 - Наши Турецкие коллеги приглашают на "живую" хирургию в конце марта!
Присоединяйтесь. Или смотри онлайн

22 января 2018 - Программа встречи "Научного авангарда" 18-20 марта опубликована!
Добро пожаловать, но по приглашению)

19 января 2018 - Ophthalmologists and the Outside World - неожиданный ракурс, "раскопанный" нашими коллегами!
Howard Fine on how external influences shaped his practice of ophthalmology, and Günther Grabner on how a career in ophthalmology shaped what he did next: archaeology

17 января 2018 - Association of Systemic Medication Use With Intraocular Pressure in a Multiethnic Asian Population: The Singapore Epidemiology of Eye Diseases Study
Key Points Question What is the association of systemic medication with intraocular pressure in a multiethnic Asian population? Findings In a post hoc analysis of a population-based study of 8063 participants from 3 ethnic groups (Chinese, Malays, and Indians), lower intraocular pressure was more likely associated with participants using systemic β-blockers, whereas higher intraocular pressure was more likely associated with participants using angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, statins, or sulfonylureas. Meaning The effect of commonly dispensed systemic medication on intraocular pressure may have implications for glaucoma risk in individuals taking these medications for coexisting comorbidities.

16 января 2018 - Уважаемые коллеги! Приглашаем Вас принять участие в работе IX Международной конференции по офтальмологии «Восток – Запад – 2018» Уфа, 7-8 июня 2018 г.
Оргкомитет: тел.: (347) 273-49-97; факс: (347) 272-08-52 Сайт конференции «Восток-Запад» www.eastwestufa.ru Сайт Уфимского НИИ глазных болезней: www.ufaeyeinstitute.ru E-mail:east-west-ufa@yandex.ru, ufaeyenauka@mail.ru

15 января 2018 - EyeNews.guru скоро с Вами!
В середине марта будет представлен широкой публике! Ждем,с!

13 января 2018 - We are pleased to announce that the Journal of Glaucoma is undergoing an affiliation change and as of now is the official scientific journal of the World Glaucoma Association
ournal of Glaucoma is currently the only scientific journal devoted to glaucoma that is both indexed and has an impact factor, giving the Journal a unique position in the glaucoma community. In conjunction with the World Glaucoma Association, the publisher will be offering remarkably low rates for both hard copy and electronic subscriptions. More information about this will follow from the publisher and the WGA once details of the new relationship are finalised.

12 января 2018 - Vernal keratoconjunctivitis
Abstract: Vernal keratoconjunctivitis (VKC) is a chronic allergic conjunctivitis that is most often seen in young, males. Although most types of allergic conjunctivitis do not affect vision, VKC is unusual in that damage to the cornea from the condition can result in vision loss. Although it is typically seasonal, year-round symptoms can be seen, which can lead to uncertain diagnoses being made. Although the pathophysiology of VKC is better understood in recent years, allowing more targeted therapies, management of these patients can still be very challenging, and complications can occur. As such, aggressive management of VKC is necessary, especially since vision loss in the amblyogenic age range can be permanent

10 января 2018 - Международная конференция «Актуальные проблемы офтальмологии», посвященная 95-летнему юбилею академика Зарифы Алиевой
Уважаемый коллега! Очередной выпуск журнала «Офтальмология» приурочен к международной конференции «Актуальные проблемы офтальмологии», посвященной 95-летнему юбилею академика Зарифы Алиевой. Просим присылать статьи на электронный адрес oftal.jurnal@mail.ru до 15.02.2018г. Требования оформления статей размещены на сайте www.oftalmologiya.az С уважением, Редакция журнала «Офтальмология»

09 января 2018 - Greeting message by the new EGS President
Ted Garway-Heath, as in-coming president, has big shoes to fill! The EGS goes from strength to strength in achieving its vision to promote the best possible well being and minimal glaucoma-induced visual disability in individuals with glaucoma within an affordable healthcare system. This would not be possible without the teamwork and friendship of many contributors

29 декабря 2017 - Refractive Surgery's Holy Grail (по информации партнеров)
Twenty-five years old is a good age to be. Any older and your hearing starts to decline; the loss may be barely detectable at that stage – but it’s only going in one direction. By the start of your fourth decade, your bone and skeletal muscle mass starts to decline, and by your mid-forties, a number of ocular diseases start to manifest: incipient cataract, slight drusen deposits, a small raise in IOP... and presbyopia. Some people experience it in their forties, others in their fifties. It’s most definitely age-related, and for now, almost certainly inescapable

23 декабря 2017 - CO Fellowships Program
The International Council of Ophthalmology (ICO) Fellowships Program was organized to help promising young ophthalmologists from developing countries improve their practical skills and broaden their perspectives of ophthalmology. Fellows are expected to bring the acquired knowledge and skills back to their home countries and take part in programs to preserve vision and prevent blindness. For the ICO-Allergan Research Fellowship we encourage applicants from all countries. The ICO gratefully recognizes grants, gifts, and pledges to the ICO Fellowships Program. Support ICO Fellowships by contributing to the ICO, ICOFoundation, or the International Ophthalmological Fellowship Foundation (IOFF). The IOFF was formed in Germany to support the fellowships. View ICO Fellowship donors.


1 2 3 4 5 6 7 8 9 10
Голосование
Что "заставляет" Вас заниматься научными исследованиями?